141 related articles for article (PubMed ID: 24445924)
21. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.
Sharma KG; Radha R; Pao A; Amet N; Baden L; Jordan SC; Toyoda M
Transpl Immunol; 2010 Jul; 23(3):117-20. PubMed ID: 20450974
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells.
Wadia PP; Herrera ND; Abecassis MM; Tambur AR
Hum Immunol; 2009 Sep; 70(9):692-700. PubMed ID: 19445989
[TBL] [Abstract][Full Text] [Related]
25. Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG4 and IgE production in vitro.
Chang CC; Aversa G; Punnonen J; Yssel H; de Vries JE
Ann N Y Acad Sci; 1993 Nov; 696():108-22. PubMed ID: 7509129
[TBL] [Abstract][Full Text] [Related]
26. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
27. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
[TBL] [Abstract][Full Text] [Related]
28. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
[TBL] [Abstract][Full Text] [Related]
29. Low-dose Anti-thymocyte Globulin Inhibits Human B-cell Differentiation into Antibody-Secreting Cells.
Klaus P; Heine G; Rasche C; Worm M
Acta Derm Venereol; 2015 Jul; 95(6):676-80. PubMed ID: 25587881
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.
Oláh AV; Asztalos L; Ivády G; Varga E; Kovács AM; Kappelmayer J; Varga J
Clin Chem Lab Med; 2011 Nov; 49(11):1849-53. PubMed ID: 21848499
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
32. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
[TBL] [Abstract][Full Text] [Related]
33. Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.
Noreikaitė A; Saint-Marcoux F; Marquet P; Kaduševičius E; Stankevičius E
Medicine (Baltimore); 2017 Mar; 96(13):e6469. PubMed ID: 28353583
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.
Eugui EM; Almquist SJ; Muller CD; Allison AC
Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Reprogramming Commits Differentiation of Human CD27
Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
[TBL] [Abstract][Full Text] [Related]
36. Investigations on the immunosuppressive activity of derivatives of mycophenolic acid in immature dendritic cells.
Iwaszkiewicz-Grzes D; Cholewinski G; Kot-Wasik A; Trzonkowski P; Dzierzbicka K
Int Immunopharmacol; 2017 Mar; 44():137-142. PubMed ID: 28092865
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes.
Heinschink A; Raab M; Daxecker H; Griesmacher A; Müller MM
Clin Chim Acta; 2000 Oct; 300(1-2):23-8. PubMed ID: 10958860
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients.
Billing H; Burmeister G; Plotnicki L; Ahlenstiel T; Fichtner A; Sander A; Höcker B; Tönshoff B; Pape L
Transpl Int; 2013 Sep; 26(9):903-9. PubMed ID: 23865768
[TBL] [Abstract][Full Text] [Related]
39. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
40. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
Berry V; Magill A; Yost M; Janosky J; Sindhi R
Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
